Baxter International Inc. announced it has appointed Stephen (Steve) H. Rusckowski, former chairman, president and chief executive officer of Quest Diagnostics Inc., to its board of directors. Effective August 21, 2023, Mr. Rusckowski serves on Baxter?s Compensation and Human Capital, and Quality, Compliance and Technology Committees. In addition, the company has announced that Michael (Mike) Mahoney will be resigning from the board effective September 13, 2023, following nearly eight years of service.

About Steve Rusckowski: Mr. Rusckowski most recently served as chairman, president and chief executive officer of Quest Diagnostics Inc. Prior to joining Quest Diagnostics, he was CEO of Philips Healthcare, and earlier in his career held roles of increasing responsibility at Hewlett-Packard Company and Procter & Gamble Company. Mr. Rusckowski currently serves as a director of Tenet Healthcare Corporation and Qiagen Inc. and previously served as a member of the boards of directors of Xerox Holdings Corporation, Covidien plc and MedQuist Inc. He earned a bachelor?s degree in mechanical engineering from Worcester Polytechnic Institute and a Master of Management Science from the Massachusetts Institute of Technology?s Sloan School of Management.